Mark Mason
Well-known member
Dash Enables Cannabis Innovation to Benefit Consumers
In a new press release, Medicinal Genomics (MGC), “an innovative company developing DNA-based testing solutions to improve cannabis cultivation productivity, quality, and safety” outlines how their partnership with Dash will disrupt the genomics, cryptocurrency, and cannabis sectors.
“A new cannabis genome reference will greatly accelerate marker-assisted selection in cannabis, while providing the industry a much needed tool to track and identify different cannabis cultivars on the Dash blockchain.”
This will allow merchants and quality testers to “monitor plants from seed to consumer” since “[a] genetic fingerprint can be readily generated using the industry standard, StrainSeek Identification and Registration Service”. This will essentially allow “biological barcodes for products in the industry”, and allow “breeders [to] now use this information to generate more productive plants”. The press release added that “[c]urrently, all publicly available reference genomes for cannabis are incomplete, containing significant gaps in the overall genomic structure”. Kevin McKernan, the Chief Science Office of MGC, believes that “one third of the cannabis genome is still undiscovered or collapsed in assembly”, but believes that they can make the referencing “50 times better than the Chemdawg reference MGC generated in 2011”.
Read more: https://www.dashforcenews.com/dash-enables-cannabis-innovation-to-benefit-consumers/
In a new press release, Medicinal Genomics (MGC), “an innovative company developing DNA-based testing solutions to improve cannabis cultivation productivity, quality, and safety” outlines how their partnership with Dash will disrupt the genomics, cryptocurrency, and cannabis sectors.
“A new cannabis genome reference will greatly accelerate marker-assisted selection in cannabis, while providing the industry a much needed tool to track and identify different cannabis cultivars on the Dash blockchain.”
This will allow merchants and quality testers to “monitor plants from seed to consumer” since “[a] genetic fingerprint can be readily generated using the industry standard, StrainSeek Identification and Registration Service”. This will essentially allow “biological barcodes for products in the industry”, and allow “breeders [to] now use this information to generate more productive plants”. The press release added that “[c]urrently, all publicly available reference genomes for cannabis are incomplete, containing significant gaps in the overall genomic structure”. Kevin McKernan, the Chief Science Office of MGC, believes that “one third of the cannabis genome is still undiscovered or collapsed in assembly”, but believes that they can make the referencing “50 times better than the Chemdawg reference MGC generated in 2011”.
Read more: https://www.dashforcenews.com/dash-enables-cannabis-innovation-to-benefit-consumers/